Cargando…

Discrepancies Between Bayesian Vancomycin Models Can Affect Clinical Decisions in the Critically Ill

PURPOSE: To assess the agreement in 24-hour area under the curve (AUC(24)) value estimates between commonly used vancomycin population pharmacokinetic models in the critically ill. MATERIALS AND METHODS: Adults admitted to intensive care who received intravenous vancomycin and had a serum vancomycin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Patanwala, Asad E., Spremo, Danijela, Jeon, Minji, Thoma, Yann, C. Alffenaar, Jan-Willem, Stocker, Sophie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9767744/ https://www.ncbi.nlm.nih.gov/pubmed/36561549 http://dx.doi.org/10.1155/2022/7011376

Ejemplares similares

Pharmacogenomic testing: perception of clinical utility, enablers and barriers to adoption in Australian hospitals
por: Pearce, Angela, et al.
Publicado: (2022)

The Significance of Bayesian Pharmacokinetics in Dosing for Critically Ill Patients: A Primer for Clinicians Using Vancomycin as an Example
por: Alnezary, Faris S., et al.
Publicado: (2023)

Discrepancy between perceptions and acceptance of clinical decision support Systems: implementation of artificial intelligence for vancomycin dosing
por: Liu, Xinyan, et al.
Publicado: (2023)

Pharmacy student-assisted medication reconciliation: Number and types of medication discrepancies identified by pharmacy students
por: Deep, Louise, et al.
Publicado: (2021)

Vancomycin therapeutic monitoring by measured trough concentration versus Bayesian‐derived area under the curve in critically ill patients with cancer
por: AbuSara, Aseel K., et al.
Publicado: (2022)

Enteral Vancomycin to Eliminate MRSA Carriership of the Digestive Tract in Critically Ill Patients
por: Buitinck, Sophie H., et al.
Publicado: (2022)

Vancomycin Area under the Curve and Pharmacokinetic Parameters during the First 24 Hours of Treatment in Critically Ill Patients using Bayesian Forecasting
por: Pongchaidecha, Manat, et al.
Publicado: (2020)

Vancomycin pharmacokinetics in critically ill obese patients: can the clinician sit back and relax?
por: Honore, Patrick M., et al.
Publicado: (2019)

Usefulness of vancomycin serum concentration monitoring in the critically ill patient
por: Bertolissi, M, et al.
Publicado: (2000)

Vancomycin is commonly under‐dosed in critically ill children and neonates
por: Sosnin, Natasha, et al.
Publicado: (2019)

Pharmacokinetics of Vancomycin in Critically Ill Children: A Systematic Review
por: Akunne, Onyinye Onyeka, et al.
Publicado: (2021)

Discrepancies between clinical and postmortem diagnoses in critically ill patients: an observational study
por: Perkins, Gavin D, et al.
Publicado: (2003)

Continuous Vancomycin Infusion versus Intermittent Infusion in Critically Ill Patients
por: Maluangnon, Chailat, et al.
Publicado: (2022)

In vitro evaluation of an intravenous microdialysis catheter for therapeutic drug monitoring of gentamicin and vancomycin
por: van der Mast, Jackelien E., et al.
Publicado: (2019)

Premortem clinical diagnoses and postmortem autopsy findings: discrepancies in critically ill cancer patients
por: Pastores, Stephen M, et al.
Publicado: (2007)

An update on drug-drug interactions for care of the acutely ill in the era of COVID-19
por: Patanwala, Asad E, et al.
Publicado: (2023)

Effect of vancomycin loading dose on clinical outcome in critically ill patients with methicillin-resistant Staphylococcus aureus pneumonia
por: Yoon, Jin Gu, et al.
Publicado: (2021)

1772. Vancomycin-Resistant Enterococcus Alters the Gastrointestinal Microbiome in Critically Ill Patients
por: Cuaresma, Edward, et al.
Publicado: (2018)

Effects of continuous venovenous hemofiltration on vancomycin trough concentrations in critically ill children
por: Peng, Lengyue, et al.
Publicado: (2021)

64. Novel Biomarkers Improve Estimation of Vancomycin Clearance in Critically Ill Children
por: Downes, Kevin J, et al.
Publicado: (2021)

Volume of distribution as an early predictor of vancomycin-induced AKI in critically ill patients
por: Ghasemiyeh, Parisa, et al.
Publicado: (2023)

Why Can't We Accurately Predict Others' Decisions? Prediction Discrepancy in Risky Decision-Making
por: Sun, Qingzhou, et al.
Publicado: (2018)

The Attitude-Behavior Discrepancy in Medical Decision Making
por: He, Fei, et al.
Publicado: (2014)

Vancomycin as a single daily dose in critically ill patients on an intensive care unit
por: Grundler, S, et al.
Publicado: (2000)

Continuous infusion of antibiotics in the critically ill: The new holy grail for beta-lactams and vancomycin?
por: Van Herendael, Bruno, et al.
Publicado: (2012)

Achievement of Vancomycin Therapeutic Goals in Critically Ill Patients: Early Individualization May Be Beneficial
por: Shahrami, Bita, et al.
Publicado: (2016)

Vancomycin levels are frequently subtherapeutic in critically ill patients: a prospective observational study
por: Bakke, V., et al.
Publicado: (2017)

A higher dose of vancomycin is needed in critically ill patients with augmented renal clearance
por: He, Juan, et al.
Publicado: (2020)

Population Pharmacokinetics and Dosing Simulation of Vancomycin Administered by Continuous Injection in Critically Ill Patient
por: Garreau, Romain, et al.
Publicado: (2021)

Major discrepancies between clinical and postmortem diagnoses in critically ill cancer patients: Is autopsy still useful?
por: Khawaja, Owais, et al.
Publicado: (2013)

Impact of a vancomycin loading dose on the achievement of target vancomycin exposure in the first 24 h and on the accompanying risk of nephrotoxicity in critically ill patients
por: Hodiamont, C J, et al.
Publicado: (2021)

On the discrepancy between professionally assessed and patient-reported outcome measures
por: Thoma, Daniel S., et al.
Publicado: (2022)

Real-Time Monitoring of Antibiotics in the Critically Ill Using Biosensors
por: Mishi, Ruvimbo Dephine, et al.
Publicado: (2023)

Discrepancy in Vancomycin AUC/MIC Ratio Targeted Attainment Based upon the Susceptibility Testing in Staphylococcus aureus
por: Eum, Seenae, et al.
Publicado: (2016)

Retrospective evaluation of possible renal toxicity associated with continuous infusion of vancomycin in critically ill patients
por: Spapen, Herbert D, et al.
Publicado: (2011)

Augmented renal clearance in critically ill patients: incidence, associated factors and effects on vancomycin treatment
por: Campassi, María Luz, et al.
Publicado: (2014)

A specially tailored vancomycin continuous infusion regimen for renally impaired critically ill patients
por: Eldemiry, Eman Mohamed Bahgat, et al.
Publicado: (2013)

Predictors of acute kidney injury under continuous infusion of vancomycin in critically ill surgical patients
por: Chackupurakal, R, et al.
Publicado: (2015)

Vancomycin therapy in critically ill patients on continuous renal replacement therapy; are we doing enough?
por: Omrani, Ali S., et al.
Publicado: (2015)

Case report: risk of skin necrosis related to injectable vancomycin in critically ill newborn infants
por: Gilliot, Sixtine, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tlr7p1b2uu9f8fhbiup1enu9us